Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial

Bibliographic Details
Title: Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
Authors: Heys, Steven D., Hutcheon, Andrew W., Sarkar, Tarun K., Ogston, Keith N., Miller, Iain D., Payne, Simon, Smith, Ian, Walker, Leslie G., Eremin, Oleg
Source: In Clinical Breast Cancer 2002 3 Supplement 2:S69-S74
Database: ScienceDirect
More Details
ISSN:15268209
DOI:10.3816/CBC.2002.s.015
Published in:Clinical Breast Cancer
Language:English